Yet, although ATP1A2 is a key player in K+ clearance, this aspect has been considered less important for the pathophysiology of migraine because the duration of the CSD was not prolonged in the FHM2 mouse model (Leo et al., 2011). This evidence concerns the gene ATP1A2 and migraine disorder.